The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $63.60

Today's change-0.09 -0.14%
Updated July 28 9:58 AM EDT. Delayed by at least 15 minutes.
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $63.60

Today's change-0.09 -0.14%
Updated July 28 9:58 AM EDT. Delayed by at least 15 minutes.

Merck & Co Inc down (U.S.)$0.09

Merck & Co Inc is lower today, dropping (U.S.)$0.09 or 0.14% to (U.S.)$63.60. Over the last five days, shares have gained 1.55% and are currently 4.79% off of the 52-week high. Shares have underperformed the S&P 500 by 4.90% during the last year.

Key company metrics

  • Open(U.S.) $63.81
  • Previous close(U.S.) $63.69
  • High(U.S.) $64.36
  • Low(U.S.) $63.22
  • Bid / Ask(U.S.) $63.60 / (U.S.) $63.61
  • YTD % change+8.03%
  • Volume2,301,696
  • Average volume (10-day)8,373,630
  • Average volume (1-month)8,712,991
  • Average volume (3-month)8,758,165
  • 52-week range(U.S.) $57.18 to (U.S.) $66.80
  • Beta0.81
  • Trailing P/E40.75×
  • P/E 1 year forward16.53×
  • Forward PEG2.81×
  • Indicated annual dividend(U.S.) $1.88
  • Dividend yield2.96%
  • Trailing EPS(U.S.) $1.56
Updated July 28 9:58 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.47%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue9,43410,11510,5369,844
Total other revenue--------
Total revenue9,43410,11510,5369,844
Gross profit7,3317,6157,9357,427
Total cost of revenue2,1032,5002,6012,417
Total operating expense7,37311,4647,6258,206
Selling / general / administrative2,4112,5642,3562,353
Research & development1,7961,2651,6451,892
Depreciation / amortization7738007721,000
Interest expense (income), net operating--------
Unusual expense (income)2904,335251544
Other operating expenses, total--------
Operating income2,061-1,3492,9111,638
Interest income (expense), net non-operating-182-180-170-171
Gain (loss) on sale of assets--------
Other--------
Income before tax2,003-1,3562,8871,504
Income after tax1,556-5872,1881,209
Income tax, total447-769699295
Net income1,551-5952,1841,205
Total adjustments to net income--------
Net income before extra. items1,551-5952,1841,205
Minority interest-5-8-4-4
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,551-5952,1841,205
Inc. avail. to common incl. extra. items1,551-5952,1841,205
Diluted net income1,551-5952,1841,205
Dilution adjustment--------
Diluted weighted average shares2,7662,7572,7862,789
Diluted EPS excluding extraordinary itemsvalue per share0.56-0.220.780.43
Dividends per sharevalue per share0.470.460.460.46
Diluted normalized EPSvalue per share0.642.421.421.22